The United Kingdom Non-Invasive Prenatal Testing Market was valued at $187 Million in 2021 and is estimated to reach a value of $481 Million by 2028 at a growth rate of 14.4%.
This new market report presents a comprehensive study of the entire United Kingdom non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the United Kingdom non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in the United Kingdom.
The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, NIPT test volume, revenues and provides forecasts through 2028. The report also includes an assessment of comparative test analysis by companies. It also covers reimbursement patterns and offers a clear view of the regulatory landscape in the United States non–invasive prenatal testing market. Key trends in terms of collaboration deals, partnerships, mergers & acquisitions, venture capital investment, distribution, and licensing agreements are analyzed in detail. The report also explores the detailed description of market drivers and inhibitors of the United Kingdom non–invasive prenatal testing market.
The report concludes with the profiles of major players in the United Kingdom non–invasive prenatal testing market. The key market players are evaluated on various parameters such as business overview, product outlook, and key development in the non–invasive prenatal testing market in the United Kingdom.
This Comprehensive United Kingdom Non-Invasive Prenatal Testing Market Research Report Provides:
• To Analyse the Historical Growth in the Market Size of the United Kingdom Non–Invasive Prenatal Testing Market from 2018 to 2021
• To Estimate and Forecast the Market Size of the United Kingdom Non–Invasive Prenatal Testing Market from 2022 to 2028 and Growth Rate until 2028
• Evaluates the Number of NIPT Tests Performed in the United Kingdom with Six Years Forecast
• Assessment of Market Potential and Opportunities for this Innovation-Driven United Kingdom Non–Invasive Prenatal Testing Market with Six Years Forecast
• Meticulously Assesses the Overall United Kingdom Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends
• Detailed Insights into the Regulatory Framework of the United Kingdom Non–Invasive Prenatal Testing Market
• Features Reimbursement Patterns of the United Kingdom Non–Invasive Prenatal Testing Market
• Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement
• A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development
The Leading Companies for the United Kingdom Non–Invasive Prenatal Testing Market are Listed Below:
• Natera Inc.
• NIPD Genetics
• Yourgene Health
• Eurofins Biomnis
• Illumina Inc.
• PerkinsElmer Inc.
• BGI Diagnosis Co. Ltd.
Key Questions Answered in this Report:
• What is the current scenario of the United Kingdom non–invasive prenatal testing market?
• What is the total market size and forecast (until 2028) for the United Kingdom non–invasive prenatal testing market?
• How has the potential United Kingdom market performed so far and how will it perform in the coming years?
• How many NIPT tests performed in the United Kingdom during 2018 – 2028?
• What are the key marketed NIPT tests available in the United Kingdom?
• What are the major drivers of the United Kingdom non–invasive prenatal testing market?
• What are the major inhibitors of the United Kingdom non–invasive prenatal testing market?
• What is the reimbursement pattern in the United Kingdom non–invasive prenatal testing market?
• What is the regulatory framework in the United Kingdom non–invasive prenatal testing market?
• What are the major deals and agreements happening in the non–invasive prenatal testing market?
• Who are the top market players? What are their happenings, current developments, and scenarios?
• How is the United Kingdom market predicted to develop in the future?
'
1. Executive Summary
2. United Kingdom Actual Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2028)
3. United Kingdom Potential Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2028)
4. United Kingdom Actual Non–Invasive Prenatal Testing Market Size and Forecast (2018 – 2028)
5. United Kingdom Potential Non–Invasive Prenatal Testing Market Size and Forecast (2018 – 2028)
6. United Kingdom Non–Invasive Prenatal Testing Market Growth Drivers and Challenges 19
6.1 Market Growth Drivers
6.2 Market Challenges
7. Non–Invasive Prenatal Testing Comparative Analysis
8. Reimbursement Environment of the United Kingdom Non-Invasive Prenatal Testing Market
9. Regulation Framework of the United Kingdom Non-Invasive Prenatal Testing Market
10. Major Deals and Agreements in the Non–Invasive Prenatal Testing Market
10.1 Collaboration Deals
10.2 Venture Capital Investment
10.3 Mergers and Acquisitions
10.4 Exclusive Agreement
10.5 Licensing Agreement
10.6 Distribution Agreement
10.7 Partnership Deals
11. Key Companies Analysis
11.1 Natera Inc.
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Recent Development
11.2 NIPD Genetics
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Recent Development
11.3 Yourgene Health
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Recent Development
11.4 Eurofins Biomnis
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Recent Development
11.5 BGI Diagnosis Co. Ltd
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Recent Development
11.6 Illumina Inc.
11.6.1 Business Overview
11.6.2 Product Portfolio
11.6.3 Recent Development
11.7 PerkinsElmer Inc.
11.7.1 Business Overview
11.7.2 Product Portfolio
11.7.3 Recent Development
List of Tables:
Table 6–1: Maternal Age at Delivery and Risk of Down Syndrome
Table 7–1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 10–1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
Table 10–2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
Table 10–3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
Table 10–4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
Table 10–5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
Table 10–6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
Table 10–7: Partnership Deals in the Non–Invasive Prenatal Testing Market
List of Figures:
Figure 2–1: United Kingdom Actual NIPT Test Volume (Number),2018 – 2021
Figure 2–2: United Kingdom Actual NIPT Test Volume Forecast (Number),2022 – 2028
Figure 3–1: United Kingdom Potential NIPT Test Volume (Number),2018 – 2021
Figure 3–2: United Kingdom Potential NIPT Test Volume Forecast (Number),2022 – 2028
Figure 4–1: United Kingdom Actual NIPT Test Market Size (Million US$),2018 – 2021
Figure 4–2: United Kingdom Actual NIPT Test Market Size Forecast (Million US$),2022 – 2028
Figure 5–1: United Kingdom Potential NIPT Test Market Size (Million US$),2018 – 2021
Figure 5–2: United Kingdom Potential NIPT Test Market Size Forecast (Million US$),2022 – 2028
